Specimen Rejection Rate serves as a critical performance indicator for laboratories, impacting operational efficiency and financial health.
High rejection rates can lead to increased costs and delays, affecting patient care and overall business outcomes.
Conversely, low rates indicate effective quality control and streamlined processes, enhancing service delivery.
Organizations that monitor this KPI can improve forecasting accuracy and align operations with strategic goals.
By leveraging analytical insights, labs can identify root causes of rejections, leading to better cost control metrics.
Ultimately, a focus on this KPI fosters data-driven decision-making and enhances the laboratory's reputation in the healthcare ecosystem.
Specimen Rejection Rate sits in the Laboratory Quality Management KPI group, where the headline co-metrics are Calibration Schedule Adherence and Test Result Reproducibility Rate. Within that group this KPI ranks fifty-second, so it is a specialized quality signal rather than a headline gauge that leaders watch first.
The canonical view places this metric on the internal process perspective of the balanced scorecard. It reads as a lagging indicator: a rejected specimen records a failure in collection, labeling, or transport that already happened, so the number rises after the pre-analytic process has broken down rather than before.
That lagging character is why it pairs naturally with leading members of the group. Calibration Schedule Adherence, the top-priority co-metric, tells you whether instruments are maintained on time, while a rejection reading tells you whether usable material even reached those instruments. Reading them together separates an intake problem from an analytical one.
A genuine tension runs against Critical Value Reporting Timeliness, another member of the group. Pressure to report urgent results inside tight windows can push staff to accept borderline specimens rather than send a fresh draw, which protects timeliness at the cost of a cleaner rejection discipline. Holding a firm acceptance standard can slow a critical result, so the two pull in opposite directions and have to be balanced deliberately.
The canonical formula divides specimens rejected by total specimens received, then expresses the result as a percentage. Two words in that formula carry most of the ambiguity: rejected and received. Settle each before you measure.
Define received first. The benchmark dimensions show sources counting requests, tubes, and specimens as their base, and those units diverge inside your own systems too. One order can generate several tubes, and one patient encounter can generate several orders. Pick the unit that matches how your lab acts on a rejection, then apply it consistently across every workstation.
Define rejected next. The benchmark populations span hematology, clinical chemistry, and general blood work, and each discipline rejects for different reasons: clotting, hemolysis, insufficient volume, mislabeling, wrong container, transport delay. Decide whether a specimen fixed and re-run counts as a rejection or only a specimen the lab could not use at all. That single fork moves the number more than almost anything else.
The data usually lives in the laboratory information system, but the honest join is to the pre-analytic record, since most rejections originate at collection rather than on the bench. Link each rejection code back to its collection location, draw team, and specimen type so the reading points to a cause rather than a total.
Segmentation matters here. Splitting by specimen type, collecting unit, and rejection reason turns one blended figure into something a team can act on, because an inpatient labeling problem and an outpatient hemolysis problem need different fixes. On instrumentation, watch for silent gaps: specimens rejected verbally at receiving that never get a code, and re-collections logged as fresh orders that quietly shrink the count. Both distort the reading unless the intake workflow captures every rejection at the point it happens.
Many laboratories overlook the importance of tracking specimen rejection rates, leading to inefficiencies that can erode trust and increase operational costs.
Enhancing specimen acceptance rates requires a focus on process optimization and staff engagement.
We have 8 relevant benchmarks in our benchmarks database.
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Africa | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Europe | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | America | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Asia | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | global | 26 articles; 16,118,499 blood sample requests |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | hematology tubes | hematology | China | 661 laboratories |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | complete blood count specimens | clinical laboratory | 703 laboratories |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | percentiles | clinical chemistry specimens | clinical laboratory | North America | 453 institutions |
Browse the Top Benchmarked KPIs in Laboratory Quality Management
The tracked sources agree on the broad idea of a rejected specimen but diverge on what they count, and those differences change what any single figure means. The clearest axis of disagreement is the denominator population. Practical Laboratory Medicine pools studies built on blood sample requests, Biochemia Medica looks at hematology tubes, and Archives of Pathology & Laboratory Medicine reports across two different bases, complete blood count specimens in one dataset and clinical chemistry specimens in another. A request, a tube, and a specimen are not interchangeable units, so a reader has to know which one a source used before comparing anything.
A second axis is discipline. Hematology material carries rejection triggers that clinical chemistry does not, and the reverse holds too, so the Biochemia Medica hematology view and the Archives clinical chemistry view are measuring related but distinct constructs. Even within one source family the population shifts, since the two Archives datasets cover different specimen types.
Geography and time period form a third axis. Practical Laboratory Medicine breaks its pooled prevalence into Africa, Europe, America, Asia, and a global figure drawn from studies spanning more than a decade, while Biochemia Medica is anchored in China and the older Archives datasets sit in North America or leave geography unstated. Collection practice, tube standards, and transport conditions differ enough across those settings that a value from one region should not be read as a target for another.
Metric type varies as well. Some Practical Laboratory Medicine entries are stated as pooled prevalence, one Archives dataset reports percentiles, and the older Archives and Biochemia Medica entries leave the metric type unstated. Pooled prevalence and a percentile distribution answer different questions, so treat them as separate lenses rather than one comparable number. Before drawing on any of these sources, confirm that its unit and discipline match how your lab defines a rejected specimen; otherwise you are comparing constructs that only look alike.
Specimen Rejection Rate ladders most directly to the group's quality objective. Objective: Improve accuracy and reliability of test results to elevate laboratory quality standards. The published key results for that objective center on reproducibility, accuracy verification, and control sample failures, and a rising share of rejected specimens undercuts all three, since material that never should have been run cannot produce reliable output. A team can carry rejection reduction as a supporting key result under this objective, for example moving the rejection reading down by a set share of a percentage point over two quarters as an illustrative target.
A second useful framing draws on the group's guidance to connect improvement work to sample integrity, which the best-practice notes tie to reducing the Sample Integrity Error Rate. Objective: Enhance regulatory compliance and audit readiness across all laboratory operations. Rejected specimens are exactly the kind of pre-analytic finding that surfaces in audits, so tracking and lowering the rejection reading gives auditors evidence that intake controls hold. Framed this way, the KPI becomes a concrete team target that ladders to audit readiness rather than a standalone quality statistic.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
Common factors include improper collection techniques, inadequate labeling, and delays in processing. Each of these issues can compromise sample integrity and lead to increased rejections.
Implementing a robust reporting dashboard can streamline tracking efforts. Regularly reviewing this data allows laboratories to identify trends and address issues proactively.
High rejection rates can lead to increased operational costs and delayed results. They can also damage relationships with healthcare providers, impacting overall business performance.
Monthly reviews are advisable for most laboratories. Frequent monitoring helps identify issues early and allows for timely interventions.
Yes, technology can enhance tracking and processing accuracy. Automated systems reduce human error and improve overall operational efficiency.
Comprehensive training ensures that staff are aware of best practices. Well-trained employees are less likely to make errors that lead to specimen rejections.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)